Drug advertising: The right or wrong prescription for our ailments?

Nature Reviews Drug Discovery

Volumn 1, Issue 11, 2002, Pages 916-920

  Brodie, Mollyann ^a   Levitt, Larry ^a  

^a HENRY J KAISER FAMILY FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CELECOXIB; ESOMEPRAZOLE; HYPOCHOLESTEROLEMIC AGENT; MONTELUKAST; ROFECOXIB; DRUG;

ARTICLE; CONSUMER; DOCTOR PATIENT RELATION; DRUG COST; DRUG INDUSTRY; DRUG INFORMATION; DRUG MANUFACTURE; DRUG MARKETING; DRUG SURVEILLANCE PROGRAM; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; MEDICARE; PHARMACEUTICAL CARE; POLITICS; PRESCRIPTION; PRIORITY JOURNAL; PROFIT; UNITED STATES; ADVERTIZING; COMPARATIVE STUDY; ECONOMICS; METHODOLOGY; REVIEW;

ADVERTISING; HUMANS; PHARMACEUTICAL PREPARATIONS; PRESCRIPTIONS, DRUG;

EID: 0036835461     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd943     Document Type: Article

References (4)

1. Kaiser Family Foundation. Prescription Drug Trends: A Chartbook Update (Kaiser Family Foundation, Menlo Park, California, November 2001).
2. Kaiser Family Foundation. Understanding the Effects of Direct-to-Consumer Prescription Drug Advertising (Kaiser Family Foundation, Menlo Park, California, November 2001).
3. Kaiser Family Foundation. National Survey of Physicians Part II: Doctors and Prescription Drugs (Kaiser Family Foundation, Menlo Park, California, March 2002).
4. Kaiser Family Foundation and Health Research and Educational Trust. Employer Health Benefits (Kaiser Family Foundation, Menlo Park, California, 2002).